Sign In
Buy VTRS
$16.31
-0.0800 (-0.488%)
At Close: Jul 14, 2026
Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTRS
08:30am, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Viagra-maker Viatris beats quarterly estimates on demand for branded drugs in China
08:19am, Thursday, 08'th May 2025
Drugmaker Viatris beat Wall Street estimates for first-quarter profit and revenue on Thursday, helped by sales of its branded drugs in China.
June 3, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTRS
07:45am, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
June 3, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTRS
07:15am, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
VTRS LAWSUIT ALERT: Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
07:00am, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatris
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
06:59am, Thursday, 08'th May 2025
Delivers Total Revenues in Line With Expectations Demonstrating Strength of the Base Business Makes Significant Pipeline Progress With Three Positive Phase 3 Data Readouts Returns More Than $450 Mil
Treatment With XULANE LO Low Estrogen Dose Achieved Primary and All Secondary Efficacy and Safety Endpoints Results Demonstrated Potential Best-In-Class Patch Performance New Drug Application Submis
Viatris' pain drug meets main goals of two late-stage trials
06:36am, Thursday, 08'th May 2025
Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.
All Primary and Secondary Endpoints Were Met in Both Phase 3 Studies In Both Acute Pain Models, MR-107A-02 Demonstrated Statistically Significant and Clinically Meaningful Improvement in Pain Compared
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS
05:45am, Thursday, 08'th May 2025
NEW YORK , May 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period
Investors Who Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky about Pending Class Action - VTRS
03:00am, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – VTRS
09:15pm, Wednesday, 07'th May 2025
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Lost Money on Viatris Inc. (VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
08:15pm, Wednesday, 07'th May 2025
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Shareholders That Lost Money on Viatris Inc. (VTRS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
04:30pm, Wednesday, 07'th May 2025
NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
